Embracing New Horizons 丨Viva Biotech's 2022 Milestones

News

}

Home / News / Company News / Company News detail

Time: 2022-12-30

Source: Viva Biotech

[Abstract]:Viva Biotech excelled in 2022, with our drug R&D and production platform leading the industry. An impressive year of growth and achievement.

Previous Page：ChemRxiv Released a Study of Diverse Heteroarene Stacking Under Physiological Conditions with Several of Viva Biotech's R&D Teams' Participation Next Page：Viva Biotech Awarded Successively “Top 20 Chinese R&D Enterprises in 2022” and Langhua Awarded “Top 20 Chinese CDMO Enterprises in 2022”

Back

Media contact: vivapr@vivabiotech.com

This site uses cookies and your privacy choices are important to us

We use cookies to improve the user experience and to analyze website traffic. By clicking "Accept", you consent to the use of cookies on our website, such as cookies policies.